Gain Therapeutics stock surges on FDA clearance for Parkinson’s drug

Investing.com Gold reports: Gain Therapeutics stock surges on FDA clearance for Parkinson’s drug. Full body text was unavailable at ingest time, so this brief is based on headline context.